House Panel May Target NIH Research, Centralize IRBs In 'Cures' Bill

The House Energy and Commerce Committee is looking at speeding medical product development process by streamlining FDA reviews, providing added exclusivity, centralizing Institutional Review Board reviews, targeting NIH grants and leveraging data, committee staff and a key lawmaker said this week as the panel moves toward a January issuance of a discussion draft bill for its 21st Century Cures initiative. Health subcommittee Chairman Joe Pitts (R-PA) said research resources, company incentives, patient engagement and data leveraging were topics that resonated...